This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,107.37 firm fixed-price delivery order is for the supply of 4566712203 - Vyvanse 30 mg capsules (100s) and does not have a set-aside designation.
DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military healthcare facilities worldwide. This contract award reflects DMS Pharmaceutical Group's capability to provide specialized medications and medical supplies to the Department of Defense.
Generated 3/13/25, 9:43 AM